To validate whether TSPAN18 increases STIM1 protein stability, TSPAN18 knockdown, TSPAN18-overexpressing and the corresponding control PCa cells were treated with cycloheximide (CHX), a protein synthesis inhibitor, and the cell lysates were collected to monitor the rate of protein degradation by WB assay. The gene discussed is STIM1; the disease is posterior cortical atrophy.